Loyola University, Cardinal Bernardin Cancer Center

Maywood, Illinois 60153

0 studies enrolling now · 8 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Acute Myelogenous Leukemia AML, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Hematological Malignancies, Hodgkin's Disease, Lymphoma, Myelodysplastic Syndrome (MDS), Myelodysplastic Syndrome MDS

Studies at this site

• Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies — Completed
• Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS — Completed
• Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL — Stopped early
• Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients — Completed
• Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies — Completed
• Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS — Status unconfirmed
• Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM — Completed
• Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65 — Stopped early